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Abstract
Background: Mice infected with HSV-1 can develop lethal encephalitis or virus induced CNS demyelination.
Multiple factors affect outcome including route of infection, virus and mouse strain. When infected with a sub-
lethal dose of HSV-1 strain 2 via the oral mucosa, susceptible SJL/J, A/J, and PL/J mice develop demyelinating
lesions throughout the brain. In contrast, lesions are restricted to the brainstem (BST) in moderately resistant BALB/
c mice and are absent in resistant BL/6 mice. The reasons for the strain differences are unknown.
Methods: In this study, we combine histology, immunohistochemistry, and in-situ hybridization to investigate the
relationship between virus and the development of lesions during the early stage (< 24 days PI) of demyelination
in different strains of mice.
Results: Initially, viral DNA and antigen positive cells appear sequentially in non-contiguous areas throughout the
brains of BALB/c, SJL/J, A/J, and PL/J mice but are restricted to an area of the BST of BL/6 mice. In SJL/J, A/J, and
PL/J mice, this is followed by the development of ‘focal’ areas of virus infected neuronal and non-neuronal cells
throughout the brain. The ‘focal’ areas follow a hierarchical order and co-localize with developing demyelinating
lesions. When antigen is cleared, viral DNA positive cells can remain in areas of demyelination; consistent with a
latent infection. In contrast, ‘focal’ areas are restricted to the BST of BALB/c mice and do not occur in BL/6 mice.
Conclusions: The results of this study indicate that susceptible mouse strains, infected with HSV-1 via the oral
mucosa, develop CNS demyelination during the first 24 days PI in several stages. These include: the initial spread of
virus and infection of cells in non-contiguous areas throughout the brain, the development of ‘focal’ areas of virus
infected neuronal and non-neuronal cells, the co-localization of ‘focal’ areas with developing demyelinating lesions,
and latent infection in a number of the lesions. In contrast, the limited demyelination that develops in BALB/c and
the lack of demyelination in BL/6 mice correlates with the limited or lack of ‘focal’ areas of virus infected neuronal
and non-neuronal cells in these two strains.
Keywords: Herpes simplex virus 1(HSV-1), Central nervous system (CNS) infection, Mouse strain, dependent effect,
HSV-1 induced CNS demyelination
Background
HSV-1 is a common infection in developed countries
where rates of seropositivity usually exceed 50% [1,2]. In
both humans and experimental animals, primary infec-
tion of the skin or mucosa results in the local replication
of virus, infection of sensory nerve endings, and spread
via retrograde axonal transport to the ganglia of the per-
ipheral nervous system (PNS) where a productive infec-
tion of neurons ensues [1,2]. Although infectious virus is
eventually cleared, a latent infection is established in
neurons of the PNS ganglia [3,4].
HSV-1infection of the CNS is more complex with
virus transmitted across synapses during primary infec-
tion and the development of latent infection in the
brains of both humans [5-7] and experimental animals
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reproduction in any medium, provided the original work is properly cited.[8-10]. In humans, HSV-1 is a common cause of spora-
dic viral encephalitis [11,12] with mortality rates reach-
ing 20-30% despite treatment [13]. Mice infected with
HSV-1 can also develop lethal encephalitis with resis-
tance to mortality being mouse strain dependent
[14,15]. Further, HSV-1 is implicated in the develop-
ment of CNS demyelinating disease in humans but its’
role remains controversial [16-20]. Although a high inci-
d e n c eo fH S V - 1i nt h eb r a i n sa n da c t i v ep l a q u e so fM S
patients is reported [21,22], virus is also present in con-
trols. Recent studies, however, report an increased risk
of MS in HSV-1 infected individuals without the
DRB1*15 allele [23]; raising the possibility that this virus
may play a role in the development of MS in individuals
with a specific genotype. HSV-1 can also induce CNS
demyelination in mice with the nature of the demyeli-
nating lesions reported to be dependent on virus strain
[24-31], route of infection [32], and mouse strain
[33,34]. The mechanisms mediating the mouse strain
effect are largely unknown. In this study, we combine
histology, immunohistochemistry, and in-situ hybridiza-
tion to investigate the relationship between virus and
the development of lesions during the early stage (< 24
days PI) of demyelination in different strains of mice.
Methods
Mice
Inbred 8-10 week ♀ BL/6, BALB/c, SJL/J, A/J, and PL/J
mice were purchased from the Jackson Laboratory, Bar
Harbor, ME. Mice were housed in animal facilities of the
Faculty of Medicine, University of British Columbia
(UBC), and infected at 10 to 12 weeks of age. Principles of
animal care (NIH publication No. 86-23, revised 1985)
were followed in these studies along with the guidelines of
the Institutional Animal Care and Use Committee of UBC.
Virus and cells
HSV-1 (strain 2) was grown on BHK-21 cells with viral
titers determined by plaque assay [35]. This strain of
HSV-1 was isolated from human trigeminal ganglia, pla-
que purified, and characterized by Dr. Moira Brown
(MRC Institute for Virology, Glasgow) [35,36]. The strain
was selected from a large number of laboratory and clini-
cal isolates because of the ability to induce CNS demyeli-
nation. Virus was stored at -80°C until used. The oral
mucosa was inoculated with a sub-lethal dose, 2 × 10
5
plaque forming units (PFU) of virus, or mock infected
using a scarification method previously described [33].
Histology
The brains of three mice of each strain were removed at
necropsy every 3 days PI and up to 30 days post-infection
(PI). Additional mice were examined on intervening days
as necessary.
Mice were perfused in-vivo with 4% paraformaldehyde
in phosphate buffered saline (PBS). CNS tissue was dehy-
drated in alcohol and toluol, embedded in paraffin, and
serially sectioned. Six micron thick coronal sections of the
cerebral hemispheres (CR) along with transverse sections
of the BST and cerebellum (CB) were made. Sections were
counter stained with either hematoxylin-eosin (H & E),
cresyl fast violet (CFV), or Luxol fast blue-cresyl fast violet
(LFB-CFV). Sections were coded and examined in a
blinded fashion with an Olympus BHS microscope.
Immunohistochemistry (IHC)
Serial sections of the CR and BST-CB were examined
by PAP IHC. Detection of HSV viral antigens
employed polyclonal rabbit anti-HSV-1 antisera
(B0114) that recognizes all viral proteins (DAKO, Bur-
lingham, ON). Sections were pretreated with 0.5%
hydrogen peroxide and washed in 0.05 M Tris-saline
(pH7.6) plus 1% normal goat serum prior to incubation
with anti-sera. This was followed by treatment with
goat anti-rabbit IgG, rabbit PAP, and 0.03% 3-3’ diami-
nobenzydine. Sections were counterstained with either
CFV or LFB-CFV.
In-situ hybridization (ISH)
Serial sections of the CR and BST-CB were examined by
ISH. Sections were mounted on glass slides, deparaffi-
nated, and rehydrated. Tissue was treated with 0.02 M
HCL, washed, and treated with 0.01% Triton X-100 in
PBS. Washed sections were treated with pronase (2.0 mg/
ml in 50 mM Tris-HCl, pH 7.4), postfixed in 4% parafor-
maldehyde in PBS, treated with 100 mM triethanlamine
(pH 8.0) plus 25 mM acetic anhydride and dehydrated in
ethanol. Sections were then treated with a prehybridiza-
tion mixture (2x SSC, formamide, Denhardt’ss o l u t i o n ,
salmon sperm DNA, dextran sulfate) for 20 min at room
temperature (RT). This was followed by treatment with a
hybridization mixture (2x SSC, dextran sulfate, formamide,
salmon sperm DNA, DTT, Denhardt’ss o l u t i o n ,
35S-
labelled HSV cDNA) at 90°C for 7 min followed by 37°C
for 16-24 hrs. The HSV cDNA probe was a 15 kb frag-
ment (fragment G) derived from HSV-1 strain F and
cloned in pTZ18. Specific activity of the probe was 2-7 ×
10
8 cpm/μg of DNA. The fragment was previously deter-
mined not to cross react with cellular DNA. The tissue
was washed, dehydrated in ethanol with 0.3 M ammonium
acetate, air dried and coated with NTB-2 emulsion. The
slides were stored at 4°C for two weeks, developed, and
counterstained with H & E.
Statistics
All analyses for statistically significant differences were
performed with Student’s t test. P <0 . 0 5i sc o n s i d e r e d
significant.
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Three HSV-1 infected mice of each strain (BL/6, BALB/
c, SJL/J, A/J, and PL/J) were examined at necropsy every
3d a y sf r o md a y0t h r o u g h3 0P I .I ns o m ec a s e s ,a d d i -
tional mice were examined on intervening days along
with mock infected controls. CR and BST-CB were seri-
ally sectioned and yielded ~300 sections of the CR and
~140 sections of the BST-CB per mouse. The serial sec-
tions were examined for viral DNA by ISH with H&E
counterstain, for viral antigen by IHC and CFV counter-
stain, or both viral antigen and demyelination by IHC
with LFB-CFV counterstain. None of the mock infected
controls were positive for HSV-1 DNA, viral antigen, or
CNS demyelination.
In BL/6 mice, HSV-1 DNA and antigen positive cells are
restricted to the BST
In BL/6 mice infected with HSV-1 strain 2 via the oral
mucosa, the spread of infectious virus is restricted to
the BST [37] and CNS demyelinating lesions do not
occur [33]. To further examine the location of viral
D N Aa n da n t i g e ni nt h eb r a i n ,H S V - 1i n f e c t e d1 0 - 1 2
week ♀ BL/6 mice were examined every 3 days from
day 0 through 30 PI. Viral DNA and antigen positive
cells cannot be identified throughout the brain nor are
they present diffusely throughout the BST (data not
shown). Viral DNA (Figure 1a-c) and antigen (Figure
1d-f) positive cells are restricted to a small area of the
BST in relation to the roots of the trigeminal nerve
(RTNBST). The appearance and clearance of viral anti-
gen in the brains of BL/6 mice is 3 and 12 days PI
respectively (Table 1) but viral DNA positive cells can
remain for at least 30 days PI (data not shown).
In BALB/c mice, HSV-1 antigen positive cells appear
sequentially in non-contiguous areas throughout the
brain
In BALB/c mice, infected with HSV-1 strain 2 via the
oral mucosa, virus spreads throughout the brain [37]
but CNS demyelinating lesions are restricted to the tri-
geminal root entry zone of the BST [33]. To identify
viral antigen in the brain, HSV-1 infected 10-12 week ♀
BALB/c mice were examined every 3 days from day 0
through 30 PI. In contrast to BL/6 mice, viral antigen
positive cells in BALB/c mice appear sequentially in
non-contiguous areas throughout the brain. Antigen
positive cells first appear in the BST on day 3 PI (Figure
2 a&2 b ) ,i nt h eC Bo nd a y6P I( F i g u r e2 d&2 e ) ,a n d
in the CR on day 7 PI (Figure 2g). Many of the cells
have the morphology of neurons (Figure 2c, 2f, & 2h).
Viral antigen positive cells also appear sequentially in
non-contiguous areas throughout the brains of SJL/J,
A/J, and PL/J mice (data not shown). In BALB/c mice,
‘focal’ areas of viral antigen positive neuronal and non-
neuronal cells are restricted to an area in relation to the
RTNBST (data not shown). The appearance and clear-
ance of viral antigen in the brains of BALB/c mice is 3
and 18 days PI respectively (Table 1) but viral DNA
positive cells can remain for at least 30 days PI (data
not shown).
In SJL/J, A/J, and PL/J mice, ‘focal’ areas of viral antigen
positive neuronal and non-neuronal cells appear
sequentially in non-contiguous areas throughout the brain
In SJL/J, A/J, and PL/J mice, infected with HSV-1 strain
2 via the oral mucosa, infectious virus spreads sequen-
tially throughout the brain [33] and is associated with
the development of early stage (< 24 days PI) CNS
demyelination throughout the brain [34]. To identify
‘focal’ areas of viral DNA and antigen positive neuronal
and non-neuronal cells throughout the brain, HSV-1
infected 10-12 week ♀ mice of all three strains were
examined every three days from day 0 through 30 PI. In
PL/J mice, ‘focal’ areas of HSV-1 DNA positive cells
appear sequentially in non-contiguous areas throughout
the brain. These areas are shown in representative sec-
tions of the BST (Figure 3a-c) and CB (Figure 3g-i).
‘Focal’ areas of viral antigen positive cells in PL/J mice
also appear sequentially in non-contiguous areas
throughout the brain. These areas are shown in repre-
sentative sections of BST (figure 3d-f) and CB (Figure
3j-l). ‘Focal’ areas of HSV-1 DNA positive and antigen
positive cells also develop throughout the brains of SJL/J
and A/J mice (data not shown). The appearance and
clearance of the ‘focal’ areas are mouse strain dependent
(Table 1).
Number and size of the ‘focal’ areas of viral antigen
positive cells define a hierarchy among different strains
of mice
The number and size of CNS demyelinating lesions
define a hierarchical order among different strains of
mice infected with HSV-1 strain 2 via the oral mucosa
[ 3 4 ] .T oi d e n t i f yt h en u m b e ra n ds i z eo f‘focal’ areas of
viral antigen positive cells in the brain, HSV-1 infected
10-12 week ♀ SJL/J, A/J, and PL/J mice were examined
every 3 days from day 0 through 30 PI. In SJL/J mice,
‘focal’ areas are few in number and small in size (Figure
4a & 4b) while in PL/J mice the areas are greater in num-
ber and larger in size (Figure 4e &4f). In A/J mice the
number and size of the ‘focal’ areas are intermediate
between SJ/L and Pl/J mice (Figure 4c &4d). The number
and size of the ‘focal’ areas also form a hierarchy among
the mouse strains.
The number and size of the ‘focal’ areas of viral anti-
gen positive cells were determined in every fourth
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Page 3 of 14Figure 1 HSV-1 DNA and antigen positive cells are not present diffusely throughout the BST of BL/6 mice but are restricted to an
area associated with the RTNBST. Ten-12 week ♀ BL/6 mice were infected with HSV-1 strain 2 via the oral mucosa. Three mice were
examined every 3 days at necropsy from day 0 through 30 PI. Six micron thick serial sections of the brain were examined for
35S-labelled HSV
DNA (ISH) and viral antigens (IHC) and counterstained with either H & E or CFV respectively. In representative sections, both viral DNA (Figure 1
a - c) and viral antigen (Figure 1 d - f) are identified on day 3 PI and restricted to a small area of the BST associated with the roots of the
trigeminal nerve (RTNBST). (a) Small area of
35S-labelled HSV DNA positive cells (arrow) in the BST on day 3 PI (x100) (b) Higher power
photomicrograph of HSV-1 DNA positive cells (arrow) on day 3 PI (x200) (c) High power photomicrograph of HSV-1 DNA positive cells on day 3
PI (x400) (d) Small area of HSV-1 antigen positive cells in the BST on day 3 PI (x100) (e) Higher power photomicrograph of HSV-1 antigen
positive cells on day 3 PI (x200) (f) High power photomicrograph of HSV-1 antigen positive cells on day 3 PI (x400).
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throughout the brains of inbred strains of mice
Mouse strain
a Initial appearance of viral
antigen positive
cells throughout the brains
Clearance of viral antigen throughout the brain (days PI)
RTNBST
b BST
c CB
d CR
e (days PI)
BL/6 3 - - - 12
BALB/c 3 3 6 7 18
SJL/J 6 6 7 8 21
A/J 3 3 6 7 21
PL/J 3 3 5 6 21
Mouse strain
a ext Initial appearance of ‘focal’ areas of viral antigen positive
cells throughout the brain
Clearance of viral antigen throughout the brain (days PI)
RTNBST
a BST
b CB
c CR
d (days PI)
BL/6 - - - - 12
BALB/c 5 - - - 18
SJL/J 9 9 12 15 21
A/J 5 5 9 12 21
PL/J 5 5 6 9 21
aTen-12 week ♀ inbred mice were infected with HSV-1 strain 2 via the oral mucosa. Three mice of each strain were examined every 3 days or as necessary from
Day 0 through 30 PI.
bRoots of the trigeminal nerve in the brainstem
cBrainstem
dCerebellum
eCerebral hemispheres
Figure 2 HSV-1 antigen positive cells appear sequentially in non-contiguous areas throughout the brains of BALB/c mice. Ten-12 week
♀ BALB/c mice were infected with HSV-1 strain 2 via the oral mucosa. Three mice were examined every 3 days at necropsy from day 0 through
day 30 PI. Serial sections of the brain were examined for viral antigens (IHC) and counterstained with CFV. In representative sections, viral
antigen was first identified in the BST on day 3 PI. (a) Viral antigen positive cells in the BST, 3 days PI (x100) (b) Higher power photomicrograph
of HSV-1 antigen positive cells on day 3 PI (x400) (c) High power photomicrograph of HSV-1 antigen positive cell with the morphology of a
neuron on day 3 PI (x1000). Viral antigen was first identified in the cerebellum (CB) on day 6 PI (d) Viral antigen positive cells in the CB, 6 days PI
(x100) (e) Higher power photomicrograph of HSV-1 antigen positive cells on day 6 PI (x400) (f) High power photomicrograph of HSV-1 antigen
positive Purkinje cells in the CB, 6 days PI (x400). Viral antigen was first identified in the cerebrum (CR) on day 7 PI (g) Viral antigen positive cells
(arrow) in the CR, 7 days PI (x200) (h) Higher power photomicrograph of HSV-1 antigen positive cells with the morphology of neurons in the CR,
7 days PI (X400).
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each of three mice of the three strains. To allow a com-
parison between the three mouse strains, IHC sections
counterstained with CFV were examined on the first
day the ‘focal’ areas appeared in the BST (day 9 PI in
SJL/J mice and day 5 PI in A/J and PL/J mice) and the
CB (day 12 PI in SJL/J mice, day 9 PI in A/J mice, and
day 6 PI in PL/J mice) (Table 2). Differences in the
Figure 3 ’Focal’ areas of HSV-1 DNA and antigen positive cells develop sequentially in non-contiguous areas of the BST and CB of PL/
J mice. Brains from 10-12 week ♀ PL/J mice, infected with HSV-1 via the oral mucosa, were examined for viral DNA and antigen. Serial sections
of the brain were examined for
35S-labelled HSV DNA (ISH) and viral antigens (IHC) and counterstained with either H & E or CFV respectively.
’Focal’ areas of
35S-labelled HSV-1 DNA (Figure 3 a-c) and viral antigen (Figure 3 d-f) positive cells are identified in the BST (a) A ‘focal’ area of
HSV-1 DNA positive cells in the BST (arrow), 3 days PI (x100) (b) Higher power photomicrograph, 3 days PI (x 200) (c) High power
photomicrograph, 3 days PI (x400) (d) A ‘focal’ area of viral antigen positive cells in the BST (arrow), 5 days PI (x100) (e) Higher power
photomicrograph, 5 days PI (x400) (f) Higher power photomicrograph of viral antigen positive neuron, 5 days PI (x400). ‘Focal’ areas of
35S-
labelled HSV-1 DNA (Figure 3g-i) and viral antigen (Figure 3 j-l) positive cells are identified in the CB. (g) A ‘focal’ area of HSV-1 DNA positive
cells in the CB (arrow), 5 days PI (x100) (h) Higher power photomicrograph, 5 days PI (x200) (i) High power photomicrograph, 5 days PI (x400) (j)
A ‘focal’ area of viral antigen positive cells in the CB, 6 days PI (x200) (k) Higher power photomicrograph, 6 days PI (x400) (l) Higher power
photomicrograph of viral antigen positive Purkinje cells, 6 days PI (x400).
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strains were statistically significant (Table 2).
Demyelinating lesions co-localize with ‘focal’ areas of HSV-1
antigen positive cells throughout the brains of SJL/J, A/J,
and PL/J mice
The relationship between ‘focal’ areas of HSV-1 antigen
positive neuronal and non-neuronal cells and demyelinat-
ing lesions throughout the brain was determined by IHC
in sections counterstained with LFV-CFV. HSV-1 infected
10-12 week ♀ SJL/J, A/J, and PL/J mice were examined
every 3 days from day 0 through 30 PI. Initially, islands of
demyelination develop either adjacent to or within ‘focal’
areas of viral antigen positive cells (Figure 5a &5b). As
viral antigen is cleared, the ‘focal’ areas decrease in size
while the demyelinating lesions increase in size (Figure 5c
&5d). Further, viral antigen positive cells in the demyeli-
nating lesions decrease in number and are eventually
cleared (Figure 5e &5f). Viral antigen is cleared through-
out the brain in all mouse strains by day 21 PI (Table 1).
Figure 4 A hierarchy exists among ‘focal’ areas of HSV-1 antigen positive cells in SJL/J, A/J, and PL/J mice. ‘Focal’ areas of viral antigen
positive cells in serial sections of the BST-CB derived from 3 mice of each strain on day 6, 9, 12, and 15 PI were examined. Serial sections were
examined by IHC and the number of ‘focal’ areas of viral antigen in the BST and CB per slide determined. As one ‘focal’ area could be present in
several serial sections, the greatest diameter of the lesion at a magnification of 400x for the BST and 200x for the CB was recorded.
Representative ‘focal’ areas of HSV-1 antigen positive cells in the BST-CB of virus infected 10-12 week ♀ mice are shown. Representative ‘focal’
areas in the BST of (a) SJL/J, 9 days PI (x400) (c) A/J, 6 days PI (x400) and (e) PL/J, 6 days PI (x400) mice are shown. Representative ‘focal’ areas in
the CB of (b) SJL/J, 12 days PI (x200) (d) A/J, 9 days PI (x200) and (f) PL/J, 6 days PI (x200) mice are also shown.
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Mouse
strain
a
BST
b examined for focal’ areas on day
(PI)
CB
c examined for ‘focal’ areas on day
(PI)
#o f‘focal’ areas
per section
d
Size of ‘focal’
area
e (μm)
SJL/J 9 12 0.6 ±
0.7
0.7 ±
0.7
97 ± 8 153 ± 6
A/J 5 9 0.7 ±
0.8
2.6 ±
1.0
156 ± 8 285 ± 9
PL/J 5 6 1.6 ±
1.0
4.6 ±
1.7
207 ±
15
373 ±
21
aThree 10-12 week ♀ mice of each strain were infected with HSV-1 strain 2 via the oral mucosa. ‘Focal’ areas of viral antigen positive cells were determined in
serial sections of the brainstem-cerebellum (BST-CB) by IHC and CFV counterstain.
bSections of the BST were examined on the first day that ‘focal’ areas appear for each mouse strain.
cSections of the CB were examined on the first day that ‘focal’ areas appear for each mouse strain.
dAverage number of ‘focal’ areas of viral antigen ± SD per section. Differences among mouse strains are all statistically significant at P < 0.001 except for the
difference between SJL/J and A/J BST which was NS.
eAs a single ‘focal’ area could be represented in several sections, the greatest diameter for each’focal’ area was determined. The average diameter ± SD of the
‘focal’ areas for the three mouse strains was then calculated. Differences between the three mouse strains are all statistically significant at P < 0.001.
Figure 5 ’Focal’ areas of HSV-1 antigen positive cells and demyelinating lesions co-localize throughout the brains of SJL/J, A/J, and
PL/J mice. Serial IHC sections counterstained with LFB-CFV were examined for ‘focal’ areas of viral antigen positive cells and CNS demyelination
in the BST and CB. ‘Focal’ areas and demyelinating lesions co-localize throughout the brains of 10-12 week ♀ SJL/J, A/J, and PL/J mice infected
with HSV-1 via the oral mucosa. Initially, island of demyelination are identified within or adjacent to ‘focal’ areas of viral antigen. Representative
sections from the CB of PL/J mice identify these areas within (white arrow) or adjacent to (black arrow) ‘focal’ areas of viral antigen (a) 8 days PI
(x200) and (b) 9 days PI (x200). As the ‘focal’ areas of viral antigen are cleared, the demyelinating lesions increase in size. Representative sections
from the CB of SJL/J mice identify areas of demyelination (arrows) adjacent to ‘focal’ areas of viral antigen (c) 14 days PI (x200) and (d) 15 days
PI (x200). Although individual antigen positive cells can remain in the demyelinating lesions for a period of time (e) antigen positive cell (arrow)
in the CB of PL/J mouse, 18 days PI (x200), ‘focal’ areas of viral antigen are eventually cleared (f) demyelinating lesions in the CB of PL/J mouse,
20 days PI (x200).
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positive cells and demyelinating lesions was determined
in every fourth section of the 140 serial BST-CB sections
obtained from each of three mice of the three strains. To
allow a comparison between the three mouse strains,
IHC sections counterstained with LFB-CFV were exam-
ined on the first day demyelinating lesions appeared in
the BST (day 12 PI in SJL/J mice and day 6 PI in A/J and
PL/J mice) and the CB (day 15 PI in SJL/J mice, day 12 PI
in A/J mice, and day 9 PI in PL/J mice) (Table 3).
Although the number of ‘focal’ areas of antigen positive
cells and demyelinating lesions is mouse strain depen-
dent (Table 3), in all mouse strains, the percentage of
demyelinating lesions that co-localize with ‘focal’ areas of
viral antigen is greater than 90%. Not all ‘focal’ areas of
viral antigen co-localized with demyelinating lesions.
Either the demyelinating lesions have yet to develop in
relation to the ‘focal’ areas of viral antigen positive cells
or not all ‘focal’ areas are associated with demyelinating
lesions.
Despite the clearance of viral antigen positive cells, HSV-1
DNA positive cells can remain in demyelinating lesions of
SJL/J, A/J, and PL/J mice
Infection of mice with HSV-1 can result in the develop-
ment of viral latency in the CNS [8-10]. The relationship
between
35S-labelled HSV-1 DNA positive cells and CNS
demyelinating lesions was examined in adjacent serial
sections of the BST-CB using histology and ISH. HSV-1
infected 10-12 week ♀ SJL/J, A/J, and PL/J mice were
examined every 3 days from day 0 through 30 PI.
Although infectious virus [34] and viral antigen (Table 1)
are eventually cleared from the brains of all three mouse
strains, the clearance of infectious virus precedes that of
viral antigen. In contrast, HSV-1 DNA positive cells can
remain in the brain beyond 25 days PI and are identified
in demyelinating lesions of all three strains (Figure 6).
This is consistent with latently infected cells remaining in
an area of demyelination.
Discussion
Mice infected with HSV-1 can develop CNS demyelinating
lesions [24-32] but their development is determined by a
number of factors including route of infection and virus
strain. When infected in the pinna of the ear, BALB/cAJcl
mice develop demyelination restricted to the descending
root of the facial nerve [32]. When infected with the Roda-
n u ss t r a i no fH S V - 1 ,b o t hS w i s sa n dB A L B / cm i c ed e v e l o p
demyelination restricted to the TREZ [24-27] but when
infected with Roziman strain F, demyelination develops in
both the TREZ and BST of the two mouse strains [28-31].
In contrast, BALB/c mice infected with a HSV-1 recombi-
nant virus expressing IL-2 develop lesions in the optic
nerve, brain, and spinal cord [38,39]. Further, BALB/c
mice infected with strains McKrae or KOS [38-40] or
BL/6 mice infected with strain McRae [40] do not develop
CNS demyelination but macrophage depleted BALB/c and
BL/6 mice, infected with strain KOS or McKrae respec-
tively, do develop lesions throughout the CNS [40]. A
number of studies performed by Ghiasi and colleagues
have implicated CD4
+CD25
+FoxP3
+ T cells as playing a
pathogenic role in the development of demyelinating
lesions when Il-12 p70 macrophages are ablated [40].
Mouse strain can also influence the development of
HSV-1 induced CNS demyelination. We previously
reported that SJL/J, A/J, and PL/J but not BL/6 mice,
infected with a sub-lethal dose of HSV-1 strain 2 via the
oral mucosa, develop demyelinating lesions throughout
the brain while lesions in BALB/c mice are restricted to
the TREZ of the BST [33,34]. The lesions are character-
ized by demyelination, a mononuclear cell infiltrate, and
relative preservation of axons [33,34,41]. Further, SJL/J,
Table 3 The relationship between ‘focal’ areas of HSV-1 antigen and demyelinating lesions in the BST-CB of inbred
strains of mice
Mouse strain
a BST
b on day (PI) CB
c on
day (PI)
#o f‘focal’
areas
d
# of lesions
e %o f‘focal’ areas
that co-localize with lesions
BST CB BST CB BST CB
SJL/J 12 15 19.7 ± 1.5 25.5 ± 4.1 18.2 ± 1.0 24.0 ± 3.7 92 94
A/J 6 12 24.8 ± 2.0 93.7 ± 1.1 24.1 ± 1.8 90.6 ± 1.0 97 97
PL/J 6 9 56.7 ± 3.1 163.7 ± 7.4 53.4 ± 2.1 162.4 ± 6.0 94 99
aThree 10-12 week ♀ mice of each strain were infected with HSV-1 strain 2 via the oral mucosa. ‘Focal’ areas of viral antigen positive cells and demyelinating
lesions were determined in serial sections of the brainstem-cerebellum (BST-CB) by IHC and LFB-CFV counterstain.
bBoth ‘focal’ areas of viral antigen and demyelinating lesions were determined in the BST of all three mouse strains. Sections of the BST were obtained on the
first day demyelinating lesions appear in that mouse strain [24].
cBoth ‘focal’ areas of viral antigen and demyelinating lesions were determined in the CB of all three mouse strains. Sections of the CB were obtained on the first
day demyelinating lesions appear in that mouse strain [24].
dAverage number of ‘focal’ areas of viral antigen ± SD in the BST and CB of each of three mice. Differences among mouse strains are all statistically significant at
P < 0.005.
eAverage number of demyelinating lesions ± SD among in the BST and CB of each of three mice. Differences among mouse strains are all statistically significant
at P < 0.005.
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Page 9 of 14A/J, and PL/J mice develop lesions sequentially through-
out the brain during the early stage (< 24 days PI), but
randomly in both A/J and PL/J mice during the inter-
mediate stage (1-3 months PI), and only in PL/J mice
during the late stage (> 3 months PI) of demyelination
[34]. During the early stage of demyelination, lesions are
immune mediated [42], and their appearance correlates
with the sequential spread of infectious virus throughout
the brain [33,37]. The number and size of the lesions fol-
low a hierarchical order among the mouse strains
Figure 6 HSV-1 DNA positive cells remain in an area of demyelination following the clearance of viral antigen.
35S-labelled HSV-1 DNA
positive cells can remain in demyelinating lesions of 10-12 week ♀SJL/J, A/J, and PL/J mice infected with virus via the oral mucosa. Adjacent
serial sections were examined by ISH and histology. In representative sections from the CB of HSV-1 infected PL/J mice (a) demyelinating lesion
are identified, 26 days PI, (x100), LFB-CFV while adjacent sections identify (b) HSV-1 DNA positive cells (arrow), 26 days PI, (x200), ISH
counterstained with H & E. (c) Higher power photo-micrograph of HSV-1 DNA positive cells (arrow), 26 days PI, (x400), ISH/H & E. (d) High power
photo-micrograph of HSV-1 DNA positive cell, 26 days PI (x1000), ISH/H & E.
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infection is recognized and defined for a number of dif-
ferent viruses [43-46], our understanding of this effect on
HSV-1 CNS infection, including the development of
demyelination, is at a preliminary stage.
In this study we combine histology, IHC, and ISH to
further define the effect of mouse strain on the develop-
ment of early stage demyelination in mice infected with
HSV-1 strain 2 via the oral mucosa.
Results of this study argue that HSV-1 induced CNS
demyelination throughout the brain in susceptible
strains of mice, develops in several stages. First, viral
DNA and antigen positive cells appear sequentially
throughout the brain, localize to non-contiguous areas
of the brain, and primarily to cells with the morphology
of neurons (Table 1). This is consistent with previous
reports on the spread and localization of HSV-1 in the
brain [47-49] resulting from transneuronal transport of
virus from the periphery to the CNS and synaptically
determined relationships in the CNS [30,49-52]. How-
ever, results of this study indicate that this does not
occur in all mouse strains. Although it is the case in
B A L B / c ,S J L / J ,A / J ,a n dP L / Jm i c e ,i ti sn o ti nB L / 6
mice where viral DNA and antigen are restricted to a
specific area of the BST. The restriction of HSV-1 to
the BST in this strain was previously identified by viral
titration studies [37] but the results of this study indi-
cate a far greater degree of restriction occurs in the BST
then was previously recognized.
Second, ‘focal’ areas of viral antigen positive neuronal
and non-neuronal cells develop throughout the brain
(Table 1). The areas appear sequentially and localize to
non-contiguous areas throughout the brain. Their devel-
opment may result from the uptake and replication of
HSV-1 in neurons resulting in the degeneration of
infected cells, loss of cellular integrity, and release of
virus [53-56]. Having a high affinity for herpes viruses
[57-59], glia can become infected in areas surrounding
the disintegrating neurons [28,31]. Further, the develop-
ment of ‘focal’ areas of viral antigen with HSV-1 has simi-
larities to other herpes virus infections including
pseudorabies virus where reactive gliosis and macrophage
infiltration provides a barrier to the diffusion of virus
through the extra-cellular compartment by isolating and
phagocytosing virus [60,61]. Results of our study identify
‘focal’ areas of viral antigen positive cells throughout the
brains of SJL/J, A/J, and PL/J mice but not in BALB/c
mice where the ‘focal’ areas are restricted to small areas
of the BST. In BL/6 mice ‘focal’ areas of viral antigen
positive cells do not develop in the brain. In the strains
developing ‘focal’ areas of viral antigen positive cells
throughout the brain, there is a hierarchical order for
size and number. Lesions are numerous and large in PL/J
mice but few in number and small in size in SJL/J mice.
A/J mice are intermediate for both number and size. The
differences are statistically significant (Table 2). Previous
studies have attributed differences in mouse strain sus-
ceptibility to the extent of glial infection with HSV-1
[33,41,62,63] while other studies have reported differ-
ences in resistance to HSV-1to be mediated directly by
glial cells [31,64,65]. A similar hierarchical order was pre-
viously identified for number and size of demyelinating
lesions developing in the same strains of mice [34].
Third, ‘focal’ areas of viral antigen positive cells co-loca-
lize with demyelinating lesions that develop throughout
the brain (Table 3). While the co-localization of ‘focal’
areas with demyelinating lesions occurs in SJL/J, A/J, and
PL/J mice, they are restricted to a small area of the BST of
BALB/c mice, and do not develop in BL/6 mice. Although
the results argue that demyelinating lesions evolve from
‘focal’ areas of antigen positive cells, it is unclear if they
develop from within or adjacent to the ‘focal’ areas.
Fourth, as ‘focal’ areas and individual viral antigen posi-
tive cells are cleared from the lesions, viral DNA positive
cells, consistent with a latent infection, remain in the
demyelinating lesions. Although viral latency in the CNS
of mice is reported after infection with HSV-1 [8-10], the
presence of latent virus within demyelinating lesions of
mice has not been previously reported to our knowledge.
Based on these results, we argue that the effect of mouse
strain on the development of CNS demyelination during
the early stage of HSV-1infection (< 24 days PI) is deter-
mined by the ability of virus to spread through the PNS
and CNS of a specific mouse strain and the ability of the
host to mount an immune response that restricts viral
spread and clears virus from the brain. In all mouse strains
infected with HSV-1 via the oral mucosa, virus spreads via
retrograde axonal transport to the TG of the PNS [1,2]
and is followed by access to the CNS. In a number but not
all mouse strains, virus spreads by transneuronal transport
throughout the brain with the development of focal and
non-contiguous neuronal infection determined by synapti-
cally defined relationships in the CNS [30,49-52]. In many
but not all mouse strains, this is followed by the develop-
ment of ‘focal’ areas of antigen positive neuronal and non-
neuronal cells that result from the replication of virus in
neurons, degeneration of infected cells, release of virus
[53-56], and subsequent infection of surrounding glia
[57-59]. The hierarchical order of number and size of
‘focal’ areas reflects mouse strain differences in resistance
of glia to HSV-1 [33,41,64,65]. An immune response clears
‘focal’ areas of viral antigen positive cells from the CNS
but results in the development of demyelinating lesions
[42]. In A/J, PL/J, and SJL/J mice, viral antigen appears
early throughout the brain but viral clearance is delayed
until day 21 PI (Table 1). A delay in the development of
an immune response in these mouse strains could explain
the delay in viral clearance and allow for the development
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ronal cells. In BL/6 mice, viral antigen also appears early
in the CNS but in contrast to other mouse strains, virus is
restricted to the BST. The restriction of viral spread and
the failure to develop ‘focal’ areas of viral antigen positive
cells is likely responsible for the absence of demyelinating
lesions. Recently, we provided evidence that the restriction
of viral spread in BL/6 mice results from redundancy in
the immune system and mediated by NK/NKT and CD8
+
T-lymphocytes [37]. Further, clearance of viral antigen
from the brains of BL/6 mice occurs on day 12 PI; earlier
then occurs in other mouse strains (Table 1). The immune
mechanisms mediating the clearance of virus has not yet
been defined. In BALB/c mice, viral antigen also appears
early throughout the brain (Table 1) but in this strain viral
clearance occurs by day 18 PI. This is delayed compared
to BL/6 mice but early when compared to SJL/J, A/J, and
PL/J mice. The delay in clearance could explain the spread
of virus throughout the brain but when compared to SJL/J,
A/J, and PL/J mice, might be sufficient to clear virus
before ‘focal’ areas of viral antigen positive cells develop.
Conclusions
When infected with a sub-lethal dose of HSV-1 lab strain
2 via the oral mucosa, susceptible SJL/J, A/J, and PL/J
mice develop demyelinating lesions throughout the brain.
In contrast, in moderately resistant BALB/c mice, demyeli-
nating lesions are restricted to the TREZ of the BST.
Resistant BL/6 mice do not develop CNS demyelination.
In this study, we combine histology, IHC, and ISH to
further investigate the effect of mouse strain on the early
stage of demyelination (< 24 days PI).
Results of this study indicate that demyelinating lesions
throughout the brain of susceptible mice develop in sev-
eral stages. Initially, viral DNA and antigen infected cells,
largely neurons, appear in non-contiguous areas through-
out the brain. This is followed by the development of
‘focal’ areas of viral antigen positive neuronal and non-
neuronal cells in non-contiguous areas throughout the
brain. The number and size of the ‘focal’ areas follow a
hierarchical order among the different mouse strains.
Next, the ‘focal’ areas of viral antigen positive cells are
seen to co-localize with demyelinating lesions suggesting
they evolve from the ‘focal’ areas. As viral antigen positive
cells and ‘focal’ areas are cleared, viral DNA positive cells
consistent with a latent infection can remain in the areas
of demyelination. All of these stages occur in susceptible
SJL/J, A/J, and PL/J mice but not in moderately resistant
BALB/c mice where ‘focal’ areas of antigen positive cells
are restricted to a small area of the BST, and not in resis-
tant BL/6 mice where ‘focal’ areas do not develop in the
brain.
We hypothesize that the development of demyelinat-
ing lesions throughout the brain of susceptible mouse
strains results from the non-contiguous spread of virus
throughout the brain and the inability of the host to
either restrict viral spread or clear virus from the brain
prior to the development of ‘focal’ areas of viral antigen
positive neuronal and non-neuronal cells.
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